Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma

Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients

COMy 2022: Multiple myeloma roundup

Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma

Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100

Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for resectable NSCLC

War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges

War in Ukraine: Current and future impacts on the Romanian cancer care system

Advance Prostate Cancer Consensus Conference 2021: Report

Recent advances in the treatment of patients with exon 20 insertion-positive NSCLC

Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy